Revenue (Tables)

3 Months Ended

Mar. 31, 2021

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	Three Months Ended March 31,
	2021	2020
Biologics	39 %	28 %
Generics	18 %	19 %
Pharma	24 %	29 %
Contract-Manufactured Products	19 %	24 %
	100 %	100 %

The following table presents the approximate percentage of our net sales by product category:

	Three Months Ended March 31,
	2021	2020
High-Value Product Components	52 %	43 %
High-Value Product Delivery Devices	5 %	5 %
Standard Packaging	24 %	28 %
Contract-Manufactured Products	19 %	24 %
	100 %	100 %

The following table presents the approximate percentage of our net sales by geographic location:

	Three Months Ended March 31,
	2021	2020
Americas	46 %	48 %
Europe, Middle East, Africa	44 %	44 %
Asia Pacific	10 %	8 %
	100 %	100 %

Schedule of Change in Contract With Customer, Asset and Liability

The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2020	$	10.9
Contract assets, March 31, 2021	12.5
Change in contract assets - increase (decrease)	$	1.6
Deferred income, December 31, 2020	$	(57.1)
Deferred income, March 31, 2021	(45.1)
Change in deferred income - decrease (increase)	$	12.0